Evidence map›Paper›PMID 39776398›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2025

Expression of vesiculation-related genes is associated with a tumor-promoting microenvironment: a pan-cancer analysis.

Luisa Westermann, Brenda Diergaarde, Simon Heidegger, Hendrik Poeck, Mirosław J Szczepański, Torsten E Reichert, Silvia Spoerl, Theresa L Whiteside, Steffen Spoerl, Nils Ludwig

Abstract read
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Luisa WestermannOral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.
Brenda DiergaardeDepartment of Human Genetics, School of Public Health, University of Pittsburgh, Pittsburgh, PA, 15213, USA.
Simon HeideggerDepartment of Medicine III, School of Medicine and Health, Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich, Germany.
Hendrik PoeckClinic and Polyclinic for Internal Medicine III, University Hospital Regensburg and Leibniz Institute for Immunotherapy (LIT), Regensburg, Germany.
Mirosław J SzczepańskiChair and Department of Biochemistry, Faculty of Medicine, Medical University of Warsaw, Warsaw, Poland.
Torsten E ReichertOral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.
Silvia SpoerlDepartment of Internal Medicine 5, Hematology/Oncology, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
Theresa L WhitesideUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Steffen SpoerlOral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.
Nils LudwigUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA. nils.ludwig.dmd@gmail.com.ORCID http://orcid.org/0000-0001-5561-2184

Funding

Small extracellular vesicles as biomarkers of prognosis and response to therapy in head and neck cancerR01DE031299 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Brenda B. Diergaarde, Theresa L. Whiteside · 2023 to 2026
$2.9M
The Adenosinergic Pathway in Tumor-derived ExosomesR01CA256068 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JACKSON, EDWIN KERRY, WHITESIDE, THERESA L. · 2021 to 2025
$2.5M
NCI NIH HHS R01 CA256068NIDCR NIH HHS R01 DE031299
6 · The paper itself

Abstract

backgroundSmall extracellular vesicles (sEV) released by tumor cells (tumor-derived sEV; TEX) mediate intercellular communication between tumor and non-malignant cells and were shown to impact disease progression. This study investigates the relationship between the expression levels of the vesiculation-related genes linked to sEV production and the tumor microenvironment (TME).

methodsTwo independent gene sets were analyzed, both previously linked to sEV production in various non-malignant or malignant cells. Expression profiles were compared among 28 tumor types listed in the Cancer Genome Atlas (TCGA). Gene expression and survival analysis (GEPIA2), immunogenomic analysis (TISIDB), and genomic analysis (GSCA) were performed.

resultsVesiculation-related genes were overexpressed in tissues of most tumor types compared to healthy tissues, and high expression levels were associated with worse overall survival in cervical squamous cell carcinoma, kidney chromophobe, lower grade glioma, hepatocellular carcinoma, lung squamous cell carcinoma, and pancreatic adenocarcinoma but with improved overall survival in kidney renal clear cell carcinoma. Expression of these signatures correlated with an increased abundance of infiltrating CD4( +) T cells and dendritic cells, a decreased abundance of B cells and eosinophils, and activation of tumor cell apoptosis and epithelial-mesenchymal transition pathways in all tumor types. 17-AAG was identified as a potential drug candidate to target tumors with elevated expression of vesiculation-related genes.

conclusionsVesiculation-related genes were associated with distinct immunological and genomic landscapes further emphasizing the important role of TEX in cancer progression.

Indexed as

Extracellular VesiclesNeoplasmsTumor MicroenvironmentGene Expression ProfilingGene Expression Regulation, NeoplasticHumansExosomesExtracellular vesiclesTumor-infiltrating immune cellsTumor microenvironmentVesiculation-related genes

Identifiers

PMID39776398
PMCPMC12178821

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.